New shot method for rare lung disease shows promise in early trial
Disease control
Completed
This study tested a new way to give a protein replacement therapy (Alpha1-Proteinase Inhibitor) by injection under the skin instead of through a vein. It involved 17 adults with Alpha1-Antitrypsin Deficiency, a genetic condition that can damage the lungs. The main goal was to che…
Phase: PHASE1, PHASE2 • Sponsor: Grifols Therapeutics LLC • Aim: Disease control
Last updated May 12, 2026 13:39 UTC